1-10 of 10
craniotomy
Close
Sort by
Journal Articles

Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas

Inyoung Lee, MS, BPharm, Sruthi Adimadhyam, BPharm, MS, Edith A. Nutescu, PharmD., MS, FCCP, Karen Sweiss, PharmD, Pritesh Patel, MD, Gregory Sampang Calip, PharmD, MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2280.
https://doi.org/10.1182/blood-2018-99-116938
Published: 2018
Journal Articles

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Sangeetha Gandhi, MBBS, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Kay M. Ristow, BS, Patrick Johnston
Journal: Blood
Blood (2018) 132 (Supplement 1): 4208.
https://doi.org/10.1182/blood-2018-99-119741
Published: 2018
Journal Articles

Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside

Pinar Ataca, MD, Selami Kocak Toprak, MD, Erden Atilla, MD, Pervin Topcuoglu, MD, Meltem Kurt Yuksel, MD, Gulsah Kaygusuz, MD, Isinsu Kuzu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Osman Ilhan, MD, Nahide Konuk, MD
Journal: Blood
Blood (2014) 124 (21): 5462.
https://doi.org/10.1182/blood.V124.21.5462.5462
Published: 2014
Journal Articles

Initial Presentation Of Multiple Myeloma As Intraparenchymal Brain Mass

Ishan Malhotra, MBBS, Abhinav B. Chandra, MD, MSc, Yiwu Huang, MD, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 5402.
https://doi.org/10.1182/blood.V122.21.5402.5402
Published: 2013
Journal Articles

CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution

Beata Ostrowska, Michal Osowiecki, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Ewa Paszkiewicz-Kozik, Lidia Poplawska, Grzegorz Rymkiewicz, Jaroslaw Stobiecki, Wojciech Michalski, Jan Walewski
Journal: Blood
Blood (2013) 122 (21): 3051.
https://doi.org/10.1182/blood.V122.21.3051.3051
Published: 2013
Journal Articles

Importance of Individualized Replacement of Factor VIII Concentrate According to Recovery Test in Hemophilia A Patient During Surgery

Ye Jee Shim, M.D., Yong-Mook Choi, M.D., Ji Yoon KIm, M.D., Kun Soo Lee, M.D.
Journal: Blood
Blood (2011) 118 (21): 4654.
https://doi.org/10.1182/blood.V118.21.4654.4654
Published: 2011
Journal Articles

Evaluation of Moyamoya Disease in Sickle Cell Anemia Patients After Encephaloduroarteriosynangiosis

Janice Earl, FNP, Peter Sun, MD, Kenneth Martin, MD, Keith C. Quirolo, MD, Elliott Vichinsky, MD, Carolyn Hoppe, MD
Journal: Blood
Blood (2011) 118 (21): 1059.
https://doi.org/10.1182/blood.V118.21.1059.1059
Published: 2011
Journal Articles

In Vivo Imaging of Cerebral Circulation In Mouse Models of Polycythemia Vera

Thom P. Santisakultarm, MS, Nozomi Nishimura, PhD, Claire Paduano, Radek C. Skoda, MD, William L. Olbricht, PhD, Andrew I. Schafer, MD, Chris B. Schaffer, PhD, Richard T. Silver, MD
Journal: Blood
Blood (2010) 116 (21): 4091.
https://doi.org/10.1182/blood.V116.21.4091.4091
Published: 2010
Journal Articles

CASE REPORT: Patient with Passovoy Defect with An Olfactory Meningioma Who Underwent Craniotomy without Bleeding Complications.

Fleur M Aung, MD
Journal: Blood
Blood (2009) 114 (22): 4204.
https://doi.org/10.1182/blood.V114.22.4204.4204
Published: 2009
Journal Articles

Von Willebrand Factor/Factor VIII Concentrate (Humate-P ® ) for Surgical Prophylaxis of Excessive Bleeding in Patients with Von Willebrand Disease (VWD).

Joan Cox Gill, MD, J. DiPaola, MD, J. Bernstein, MD, C. A. Leissinger, MD, L. Valentino, MD, C. Friedman, MD, S. Knaub
Journal: Blood
Blood (2005) 106 (11): 1791.
https://doi.org/10.1182/blood.V106.11.1791.1791
Published: 2005